Gentris Clinical Genetics announced the appointment of Dawn Bordeaux as its chief operating officer, L. Scott Clark as chief scientific officer, and Suzanne Phillips as VP of scientific operations. Previously at the company, Bordeaux was VP of quality assurance and finance, Clark was the VP of scientific operations, and Phillips was the senior director of research and development.